Basic Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Mar 28, 2016; 22(12): 3363-3371
Published online Mar 28, 2016. doi: 10.3748/wjg.v22.i12.3363
Table 1 Body weight, vasopressin and serum sodium in baseline conditions in cirrhotic rats prior to receiving tolvaptan (3 mg/kg), tolvaptan (5 mg/kg) or vehicle
1 d2 d3 d4 d5 d
Body weight (g)Vehicle486.7 ± 12.57 (5)492.1 ± 10.12 (5)472.8 ± 18.21 (5)475.2 ± 9.21 (5)482.8 ± 13.24 (5)
Tolvaptan (3 mg/kg)502.3 ± 11.91 (6)487.3 ± 12.43 (6)465.6 ± 16.59 (6)465.6 ± 13.24 (6)476.3 ± 16.00 (5)
Tolvaptan (5 mg/kg)493.4 ± 16.34 (6)485.2 ± 20.21 (6)490.1 ± 13.12 (6)472.1 ± 12.12 (6)490.1 ± 11.12 (6)
Vasopressin(pg/L)Vehicle13.25 ± 1.24 (5)14.15 ± 1.41 (5)15.44 ± 1.38 (5)14.99 ± 0.94 (5)13.05 ± 0.85 (5)
Tolvaptan (3 mg/kg)15.29 ± 0.93 (6)13.37 ± 1.22 (6)16.87 ± 0.73 (6)15.16 ± 1.17 (6)14.33 ± 0.99 (5)
Tolvaptan (5 mg/kg)14.85 ± 1.39 (6)14.23 ± 0.81 (6)15.12 ± 1.21 (6)13.21 ± 1.21 (6)15.23 ± 0.81 (6)
Serum sodium (mol/L)Vehicle141.2 ± 1.31 (5)141.2 ± 1.11 (5)139.2 ± 0.75 (5)140.1 ± 0.92 (5)140.2 ± 1.31 (5)
Tolvaptan (3 mg/kg)139.2 ± 1.27 (6)141.3 ± 1.20 (6)138.2 ± 1.85 (6)140.1 ± 1.23 (6)138.2 ± 1.87 (5)
Tolvaptan (5 mg/kg)141.2 ± 1.21 (6)140.9 ± 1.12 (6)142.2 ± 1.22 (6)138.1 ± 2.21 (6)139.1 ± 1.55 (6)